Methylphenidate-Induced Enuresis: 3 Case Reports.

Clin Neuropharmacol

Department of Child and Adolescent Psychiatry, Konya Training and Research Hospital, Konya, Turkey.

Published: September 2021

Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder in children and adolescents. Methylphenidate (MPH) is one of the most widely used drugs in the treatment of ADHD. Enuresis can occur comorbidly with ADHD. However, enuresis is sometimes seen in patients with ADHD as an adverse effect of MPH treatment. In contrast, in some cases, MPH reportedly improves enuresis in patients with ADHD comorbid with enuresis. The literature is contradictory with regard to the relationship between MPH and enuresis. This report presents the cases of 3 children with ADHD who displayed enuresis during MPH treatment.

Download full-text PDF

Source
http://dx.doi.org/10.1097/WNF.0000000000000422DOI Listing

Publication Analysis

Top Keywords

adhd enuresis
8
enuresis patients
8
patients adhd
8
mph treatment
8
adhd
6
enuresis
6
mph
5
methylphenidate-induced enuresis
4
enuresis case
4
case reports
4

Similar Publications

Cleft palate, congenital heart disease, and developmental delay involving heterozygous mutations found in the patient with attention deficit hyperactivity disorder: a case report.

Front Pediatr

December 2024

Key Laboratory of Birth Defects and Related Diseases of Women and Children of Ministry of Education (MOE), Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China.

This case is the first reported patient with a gene mutation who primarily exhibits pronounced inattention as the main manifestation and is diagnosed with ADHD, requiring methylphenidate treatment. It is characterized by unique clinical features that set it apart from previously reported cases with mutations in the gene. Here, we report a female child with a diagnosis of ADHD and comorbidities.

View Article and Find Full Text PDF

Aims: Sleep disordered breathing (SDB), lower urinary tract dysfunction (LUTD), and enuresis (NE) are common in children and adolescents and have serious consequences, especially on social and emotional development. Even though much is known about the association between SDB and NE among adults, the number of articles in children and adolescents is limited. Therefore, the aim of the present scoping review was to map out the current knowledge about SDB and LUTD in children and adolescents.

View Article and Find Full Text PDF

Early Positive Report of Viloxazine for a Child with Hyperkinetic Autism.

Psychopharmacol Bull

January 2025

Alamiri, MD, ABPN, ScD, Al-Manara CAP Centre, Kuwait Centre for Mental Health (KCMH), Shuwaikh, State of Kuwait.

Herein, authors report on an ASD child with comorbid ADHD, ID, metabolic syndrome and nocturnal enuresis that failed multiple trials of psychotropic agents for behavioural dyscontrol. Viloxazine adjuventia brought about remarkable improvement spanning different domains. Purported pharmacodynamic mechanisms are briefly discussed.

View Article and Find Full Text PDF

Aim: To investigate urinary incontinence prevalence and its association with neurodevelopmental disorders among children in Japan.

Methods: A web-based survey was conducted on children aged 5-15 years in Japan. Information on daytime and nocturnal incontinence and neurodevelopmental disorders, such as attention deficit hyperactivity disorder, autism spectrum disorder, and intellectual disability, was collected.

View Article and Find Full Text PDF

Exploring the Genetic Risk of Childhood Daytime Urinary Incontinence: A Genome-Wide Association Study.

J Urol

December 2024

The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Copenhagen and Aarhus, Denmark.

Article Synopsis
  • - The study investigates childhood daytime urinary incontinence (DUI) by identifying genetic variants that increase the risk, shedding light on the condition which is often stigmatized and not well understood.
  • - A genome-wide association study was performed on a large cohort from Denmark and replicated in Iceland, discovering significant genetic variants on chromosomes 6 and 20 linked to genes involved in neuronal development and bladder function.
  • - The research found that DUI has a hereditary component and is genetically correlated with conditions like attention-deficit/hyperactivity disorder and BMI, suggesting new directions for treatment options.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!